Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

active_not_recruiting125%
completed375%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES)

NCT04143126
completednot_applicable

Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder

NCT03170453
completednot_applicable

Brain Imaging, Cognitive Enhancement and Early Schizophrenia

NCT01561859
completednot_applicable

Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder

NCT00902798

Clinical Trials (4)

Showing 4 of 4 trials
NCT04143126Not Applicable

Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES)

Active Not Recruiting
NCT03170453Not Applicable

Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder

Completed
NCT01561859Not Applicable

Brain Imaging, Cognitive Enhancement and Early Schizophrenia

Completed
NCT00902798Not Applicable

Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4